Get started

Morganstanley

Will Morgan Stanley Bank continue in selloff?Morgan Stanley - 30d expiry - We look to Sell a break of 83.18 (stop at 86.32) Short term bias has turned negative. There is no indication that the selloff is coming to an end. This stock fell 6.5 % last week. A break of the recent low at 83.28 should result in a further move lower. Short term MACD has turned negative. Our profit targets will be 75.33 and 73.33 Resistance: 89.18 / 92.00 / 93.50 Support: 87.00 / 83.28 / 81.00 Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Signal Centre’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Signal Centre.
NYSE:MSShort
by VantageMarkets
MS - Short PositionOn the chart we can see the raising wedge pattern. It seems that the wedge is in its early stage of development. We are expecting that the price will be consolidating inside the wedge for a while, before the breakout. RSI currently is showing oversold conditions, therefore we believe that the price will bounce from the upsloping support. We would enter the short position when (only if ) the price breaks down of the wedge. Possible path is shown on the chart. The target will be determined once the breakout occurs. Good luck
NYSE:MSShort
by vf_investment
5
Morgan Stanley Loosing. MSEnd of an upgoing impulse confirmed, initiating a new downward ABC pattern. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe.
NYSE:MSShort
by Rykin_Capital
MS: Medium term bears!Morgan Stanley Short Term - We look to Sell at 87.23 (stop at 89.69) The medium term bias remains bearish. There is scope for mild buying at the open but gains should be limited. Prices expected to stall near trend line resistance. Further downside is expected. Preferred trade is to sell into rallies. Our profit targets will be 80.98 and 79.00 Resistance: 92.40 / 109.00 / 120.00 Support: 81.00 / 72.50 / 53.00 Please be advised that the information presented on TradingView is provided to Vantage (‘Vantage Global Limited’, ‘we’) by a third-party provider (‘Signal Centre’). Please be reminded that you are solely responsible for the trading decisions on your account. There is a very high degree of risk involved in trading. Any information and/or content is intended entirely for research, educational and informational purposes only and does not constitute investment or consultation advice or investment strategy. The information is not tailored to the investment needs of any specific person and therefore does not involve a consideration of any of the investment objectives, financial situation or needs of any viewer that may receive it. Kindly also note that past performance is not a reliable indicator of future results. Actual results may differ materially from those anticipated in forward-looking or past performance statements. We assume no liability as to the accuracy or completeness of any of the information and/or content provided herein and the Company cannot be held responsible for any omission, mistake nor for any loss or damage including without limitation to any loss of profit which may arise from reliance on any information supplied by Signal Centre.
NYSE:MSShort
by VantageMarkets
BNTC Gene Therapy Penny StockBTC Benitec Biopharma is sitting now at a key support from which we can expect a bounce. We know that earlier this year they had a 7.5mil offering price to the public of $4.25 per share and that Morgan Stanley has a 5.2% stake in the genetic drug company. Benitec's "proprietary platform, called DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitate sustained silencing of disease-causing genes following a single administration. Market Cap 22.472Mil My price targets are 4.70 and 5.70 usd.
NASDAQ:BNTCLong
by TopgOptions
Morgan StanleyHello Traders, welcome to this free and educational analysis. I am going to explain where I think this asset is going to go over the next few days and weeks and where I would look for trading opportunities. If you have any questions or suggestions which asset I should analyse tomorrow, please leave a comment below. I will personally reply to every single comment! If you enjoyed this analysis, I would definitely appreciate it, if you smash that like button and maybe consider following my channel. Thank you for watching and I will see you tomorrow!
NYSE:MS
by basictradingtv
6
INSTITUTIONAL TRADE: Long USDCAD – MORGAN STANLEYMorgan Stanley recommends a buy in USDCAD. Rationale: We think global reflation is largely in the price, leaving limited room for global growth to surprise to the upside. US growth outperformance relative to Canadian growth (and higher US real yields) are consistent with USD/CAD gains. We think oil prices will struggle to rally above $70bbl, weighing on CAD, and investors are currently positioned short USD/CAD. Key catalysts: The BoC’s taper pace and output gap projection, oil prices, US Fed policy guidance. Over the next few months, we expect CAD to soften as the recent acceleration in global growth hits a slower inflection point, domestic growth meets (but does not exceed) market expectations and US real yields rise as a Fed taper approaches. We think Brent is unlikely to rise above $70bbl in the near term, 2y yield differentials no longer exert downward pressure on USD/CAD, and investors are already positioned for CAD strength. Positioning: Investors maintained long USD/CAD positions for much of 2020 despite the grind lower in the pair. However, following CAD outperformance year-to date in 2021, CFTC data suggest that investor positioning has now flipped to being most long CAD among all G10 currencies. That switch reflects two changes: a rise in long CAD positions among asset managers to decade highs, and a paring back of leveraged funds short CAD positions. Long CAD positions, therefore, mostly reflects net positioning among long-term investors. While long CAD positioning mostly reflects wagers made by long-term investors, backtesting reveals that both leveraged fund and asset manager positioning have historically been contrarian indicators, rather than momentum indicators. A contrarian indicator means that long positioning means poor forward returns, and vice versa. A similar picture emerges in other positioning data. A key trader survey (the daily sentiment index) indicates that investors are bullish CAD. While this survey has historically been a momentum indicator when investors are extremely bearish on CAD (i.e., bullish USD/CAD), it can be a contrarian indicator when investors are extremely bullish on CAD (i.e., bearish USD/CAD). Risks: The risk is that the USD continues to broadly depreciate amid lower US real yields and wider breakevens, which would likely push USD/CAD below 1.20 to a meaningful degree.
by thunderpips
2
BNTC Benitech Biopharma we bought the dipMorgan Stanley disclosed in an SEC filing that it had increased its stake in the company by around 5.2%! Don`t worry, it has still upside potential, despite the 130% increase in the Pre-Market. Market Cap of only 15.37M This is a 5X stock, Not trading advice as you know! :) This was a private call from my trading group and one of my top picks for March. You can check the transcripts here: www.patreon.com If you are also interested to test some amazing BUY and SELL INDICATORS that i use, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
NASDAQ:BNTCLong
by TopgOptions
16
BURGERFI BUY IDEANASDAQ:BFI What do Americans love the most? The good ol' hamburger! The Numbers: (2019 Financials) - $18.40 average transaction - $13.01 average per person check - 44.75% Prime Margin - Adjusted EBITDA = $3,690 (In thousands) Projections: - 2021 Expected Revenue ~ $160 million - 2021 Expected EBITDA ~ $10.5 million Current Partnerships: - Expansion of "Ghost Kitchens", 25 committed kitchens by December 31st, 2021 - US Air Force, planned bases in Arizona, Colorado, Alaska, Georgia, and Nebraska (For 2021/2022) Potential of more branch partnerships Big Names invested: Lion Point Capital - 2,745,938 shares Morgan Stanley - 205,329 shares All in all, whether this be a long term hold or a swing trade, the value area to buy into is zoned on the chart. Point of Control is located around $13. Once entered into the trade, be sure to take profits if previous highs are taken out. If the value area fails, I plan to hold below it since the majority of shares were accumulated at $10. Reference: d1io3yog0oux5.cloudfront.net
B
by UnknownUnicorn1946597
1